Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Noven Pharmaceuticals Inc

Noven Pharmaceuticals Inc Recalls

All product recalls associated with Noven Pharmaceuticals Inc.

Get alerts for this brand

Recall Summary

Total Recalls

Past Year

Class I (Serious)

Most Recent

Oct 2024

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–20 of 51 recalls

Xelstrym (Noven) – Defective Delivery System (2024)

Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive).

Class IIModerate

FDAOct 31, 2024Nationwide• Noven Pharmaceuticals Inc

Daytrana 30mg Patch (Noven) – Delivery System Defect (2023)

Defective Delivery System: Out of specification for shear.

Class IIModerate

FDAMar 10, 2023Nationwide• Noven Pharmaceuticals Inc

Daytrana 15mg Patch (Noven) – Delivery System Defect (2023)

Defective Delivery System: Out of specification for shear.

Class II

12 3

Page 1 of 3Next

Moderate

FDAMar 10, 2023Nationwide• Noven Pharmaceuticals Inc

Daytrana 10mg Patch (Noven) – Delivery System Defect (2023)

Defective Delivery System: Out of specification for shear.

Class IIModerate

FDAMar 10, 2023Nationwide• Noven Pharmaceuticals Inc

Daytrana 20mg Patch (Noven) – Delivery System Defect (2023)

Defective Delivery System: Out of specification for shear.

Class IIModerate

FDAMar 10, 2023Nationwide• Noven Pharmaceuticals Inc

Daytrana (Noven) – Defective Adhesive System (2022)

Defective Delivery System: Recalled lot was found to be out of specification for shear. Shear is an attribute related to the adhesive properties of the transdermal patches.

Class IIModerate

FDANov 16, 2022Nationwide• Noven Pharmaceuticals Inc

Daytrana Patch (Noven) – Delivery System Defect (2022)

Defective Delivery System: Customer complaints received for ripping patches and tight release/adhesive transfer.

Class IIModerate

FDAJun 24, 2022Nationwide• Noven Pharmaceuticals Inc

Daytrana (Noven) – Delivery System Defect (2022)

Defective Delivery System: customer complaints exceeded respective action limits.

Class IIModerate

FDAMay 6, 2022Nationwide• Noven Pharmaceuticals Inc

Combipatch 0.05/0.25mg (Noven) – Stability Failure (2021)

Failed Stability Specifications; out of specification for shear.

Class IIModerate

FDAJul 30, 2021Nationwide• Noven Pharmaceuticals Inc

Combipatch 0.05/0.14mg (Noven) – Stability Failure (2021)

Failed Stability Specifications; out of specification for shear.

Class IIModerate

FDAJul 30, 2021Nationwide• Noven Pharmaceuticals Inc

Daytrana 10mg (Noven) - Patch Defect (2021)

Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits.

Class IIModerate

FDAMay 20, 2021Nationwide• Noven Pharmaceuticals Inc

Daytrana 15mg (Noven) - Patch Defect (2021)

Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits.

Class IIModerate

FDAMay 20, 2021Nationwide• Noven Pharmaceuticals Inc

Minivelle Patch (Noven) – adhesive defect (2021)

Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience patches that do not stick well to the skin.

Class IIModerate

FDAApr 16, 2021Nationwide• Noven Pharmaceuticals Inc